Davies AM - Search Results

1

Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.

Lynch TJ, Bonomi PD, Butts C, Davies AM, Engelman J, Govindan R, Herbst RS, Heymach JV, Johnson BE, Martins RG, Perez-Soler R, Riely GJ, Sandler AB, Sequist LV, Socinski MA, Wong KK, Hart CS. Lynch TJ, et al. Among authors: davies am. Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4583-8. doi: 10.1158/1078-0432.CCR-07-0716. Clin Cancer Res. 2007. PMID: 17671145

2

Efficacy and safety of single-agent pertuzumab, a human epidermal receptor dimerization inhibitor, in patients with non small cell lung cancer.

Herbst RS, Davies AM, Natale RB, Dang TP, Schiller JH, Garland LL, Miller VA, Mendelson D, Van den Abbeele AD, Melenevsky Y, de Vries DJ, Eberhard DA, Lyons B, Lutzker SG, Johnson BE. Herbst RS, et al. Among authors: davies am. Clin Cancer Res. 2007 Oct 15;13(20):6175-81. doi: 10.1158/1078-0432.CCR-07-0460. Clin Cancer Res. 2007. PMID: 17947484 Clinical Trial.

3

Systemic therapy of bronchioloalveolar carcinoma: results of the first IASLC/ASCO consensus conference on bronchioloalveolar carcinoma.

Kris MG, Giaccone G, Davies A, Fukuoka M, Garfield DH, Jassem J, Quoix EA, Sandler AB, Scagliotti GV, Van Meerbeeck JP, West H. Kris MG, et al. J Thorac Oncol. 2006 Nov;1(9 Suppl):S32-6. J Thorac Oncol. 2006. PMID: 17409999 Free article.

4

Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer.

Gandara D, Narayan S, Lara PN Jr, Goldberg Z, Davies A, Lau DH, Mack P, Gumerlock P, Vijayakumar S. Gandara D, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5057s-5062s. doi: 10.1158/1078-0432.CCR-05-9012. Clin Cancer Res. 2005. PMID: 16000614 Review.

5

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

Ho C, Davies AM, Lara PN Jr, Gandara DR. Ho C, et al. Among authors: davies am. Clin Lung Cancer. 2006 May;7 Suppl 4:S118-25. doi: 10.3816/clc.2006.s.003. Clin Lung Cancer. 2006. PMID: 16764752 Review.

6

Incorporating bortezomib into the treatment of lung cancer.

Davies AM, Lara PN Jr, Mack PC, Gandara DR. Davies AM, et al. Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4647-51. doi: 10.1158/1078-0432.CCR-07-0334. Clin Cancer Res. 2007. PMID: 17671158 Review.

7

Treatment of recurrent small cell lung cancer.

Davies AM, Evans WK, Mackay JA, Shepherd FA. Davies AM, et al. Hematol Oncol Clin North Am. 2004 Apr;18(2):387-416. doi: 10.1016/j.hoc.2003.12.010. Hematol Oncol Clin North Am. 2004. PMID: 15094178 Review. No abstract available.

8

Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions.

Gautschi O, Mack PC, Davies AM, Jablons DM, Rosell R, Gandara DR. Gautschi O, et al. Among authors: davies am. Clin Lung Cancer. 2008;9 Suppl 3:S129-38. doi: 10.3816/CLC.2008.s.019. Clin Lung Cancer. 2008. PMID: 19419927 Review.

9

Predictive molecular markers: has the time come for routine use in lung cancer?

Davies AM, Mack PC, Lara PN Jr, Lau DH, Danenberg K, Gumerlock PH, Gandara DR. Davies AM, et al. J Natl Compr Canc Netw. 2004 Mar;2(2):125-31. doi: 10.6004/jnccn.2004.0011. J Natl Compr Canc Netw. 2004. PMID: 19777702 Review.

10

Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer.

Davies A, Gandara DR, Lara P, Goldberg Z, Roberts P, Lau D. Davies A, et al. Semin Oncol. 2002 Jun;29(3 Suppl 12):10-6. doi: 10.1053/sonc.2002.34257. Semin Oncol. 2002. PMID: 12170446 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

677 results

Search Page